IRAG working group 3. Cell function-based assays. Interagency Regulatory Alternatives Group

Current methods for ocular irritancy testing rely heavily on animal models, which raise ethical concerns and may not fully capture human responses. Prior research has shown that cell-based assays can detect changes in cell function and barrier integrity, but their use in regulatory testing remains limited. No prior work had resolved how best to translate these assays into standardized protocols for surfactant-based products. This gap motivated the development of cell function-based assays as alternatives to traditional methods. The fluorescein leakage assay has been proposed as a model for epithelial barrier function, but its utility is still under investigation. The silicon microphysiometer test has been studied for metabolic effects, but its reproducibility across formulations is not fully established. This uncertainty drove the need for systematic evaluation of these methods. Researchers have already shown that L929 cells respond to irritants, but the extent of their applicability is unclear. The lack of standardized protocols for these assays remains a challenge in their adoption.

This work aimed to assess the potential of cell function-based assays for ocular irritancy testing. The specific problem addressed is the need for reliable in vitro alternatives to animal testing for surfactant-based products. The motivation stems from the limitations of current methods and the push for ethical and predictive testing. The fluorescein leakage assay was evaluated for its ability to detect effects on epithelial barrier function. The silicon microphysiometer test was assessed for its correlation with in vivo irritancy. The goal was to determine if these assays could serve as screening tools for surfactants and alcohols. The study focused on optimizing and standardizing the protocols for these assays. The researchers sought to validate the reproducibility of the methods across different formulations. This work contributes to the development of regulatory alternatives in toxicology.

The study utilized two primary cell-based assays: the fluorescein leakage and silicon microphysiometer tests. The fluorescein leakage assay involved measuring barrier function in epithelial cell monolayers or multilayers. MDCK and NHEK cells were used as models for corneal epithelial function. The test assessed how substances affected the integrity of these cell layers at sublytic concentrations. The silicon microphysiometer test monitored changes in cell metabolism in response to test substances. L929 cells were selected as the cell type for this assay. The method involved measuring metabolic rates to predict irritancy potential. Three data submissions from the IRAG group were analyzed for the microphysiometer test. The fluorescein leakage assay required further optimization and standardization. The study compared in vitro results with in vivo data to assess correlations.

The fluorescein leakage assay showed potential as a screening test for surfactants and alcohols. Two IRAG data submissions indicated that the assay could detect effects on epithelial barrier function. However, the method requires further optimization to confirm its utility fully. The silicon microphysiometer test demonstrated strong in vivo/in vitro correlations for surfactant-based products. Three IRAG data submissions supported the reproducibility of this method. The test was effective for aqueous-soluble liquid formulations with mild to moderate irritancy. L929 cells were used consistently for the microphysiometer test. The results suggest that the method is suitable for ocular irritancy screening. Both assays require further evaluation for standardization and regulatory acceptance. The findings highlight the potential of cell function-based tests as alternatives to animal models.

The authors propose that cell function-based assays may serve as alternatives to animal testing for ocular irritancy. The fluorescein leakage assay shows promise for surfactants and alcohols but requires further optimization. The silicon microphysiometer test demonstrated strong correlations with in vivo data. The reproducibility of the microphysiometer method supports its use for screening surfactant-based products. Both assays need standardization to ensure consistent results. The study suggests that these methods may be useful for regulatory testing. However, the authors caution that further evaluation is necessary before full implementation. The findings align with the goal of developing ethical and predictive in vitro testing methods.